The Lineberger Comprehensive Cancer Center (LCCC) Administrative Core includes the Senior Leadership Team (SLT) and Center Administraion. The SLT establishes the overall strategic direction and research mission for LCCC and center Adminstration operationalizes this vision. The SLT includes the Director and Associate Directors of Clinical; Basic; Population Science; Translational Research; Education and Training; and Administration that meet weekly to consider all matters impacting LCCC. Center Administration provides infrastructure to promote the cancer research activities of its 300 members, with a particular focus on facilitating transdisciplinary and translational cancer research. The Administration supports the Director, Senior Leaders, Program Leaders, Shared Resources Directors and LCCC Members in carrying out the Center mission through effective strategic planning and evaluation, operational management, and centralized resources. LCCC Administration (72 FTE/$14M) oversees the largest research operation at the University including a $156M budget (FY14) including grant and fiscal management and other administrative services for 134 faculty members and 15 Shared Resources. Many of these reside in center-controlled space (153,000 nsf) which the administrative staff also manages. The administrative staff is responsible for Human Resources and administering partial salary support for over 1200 FTEs. Administrative responsibilities include: management of Center finances, personnel, grants and contracts, purchasing, and philanthropy; provide administrative and financial oversight LCCC shared resources; oversee space utilization and common equipment; facilitate recruitment efforts; manage center membership; and coordinate and facilitate pilot award programs and Center planning and evaluation activities (leadership and programmatic meetings, seminars, annual symposia and retreats, and internal and external board meetings). The administrative staff also supports communication to the 300 LCCC members and the University as a whole as well as educating citizens and legislators regarding Center activities across the state. The Administrative Core monitors and reports on member accomplishments, funding, cancer-related activity to the membership committee and SLT as a part of the annual membership evaluation. The conduct of surveys and evaluation for planning is also a function of the central administrative staff. The Administrative Core functions are overseen by two leaders with 30 and 15 years' experience at UNC Lineberger and a dynamic new Associate Director for Administration. For Year 40, the Center requests a committed level of $737,324 to support 6.45 FTEs plus costs for supplies, travel, and other operational expenses to support the Administrative Core. The center Administration portion ($455,089 and 5.2FTE) represents 9% of the overall CCSG budget request and 3% of the Administration operating budget ($14M). The requested budget for Administration is equivalent to the 2010 budget despite increased Center funding, space, and personnel.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016086-43
Application #
9614897
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2018-12-01
Budget End
2019-11-30
Support Year
43
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Trout, Susan; Goldstein, Adam O; Marks, Lawrence et al. (2018) Treating Tobacco Use in Patients with Incurable Malignancies: Should We Even Start the Conversation? J Palliat Med 21:746-750
Lee, Clara Nan-Hi; Pignone, Michael Patrick; Deal, Allison M et al. (2018) Accuracy of Predictions of Patients With Breast Cancer of Future Well-being After Immediate Breast Reconstruction. JAMA Surg 153:e176112
Ricketts, Christopher J; De Cubas, Aguirre A; Fan, Huihui et al. (2018) The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep 23:313-326.e5
Golden, Shelley D; Kong, Amanda Y; Lee, Joseph G L et al. (2018) Disparities in cigarette tax exposure by race, ethnicity, poverty status and sexual orientation, 2006-2014, USA. Prev Med 108:137-144
Song, Wantong; Shen, Limei; Wang, Ying et al. (2018) Synergistic and low adverse effect cancer immunotherapy by immunogenic chemotherapy and locally expressed PD-L1 trap. Nat Commun 9:2237
Kaur, Gurpreet; Guruprasad, Kunchur; Temple, Brenda R S et al. (2018) Structural complexity and functional diversity of plant NADPH oxidases. Amino Acids 50:79-94
McNeill, Robert S; Stroobant, Emily E; Smithberger, Erin et al. (2018) PIK3CA missense mutations promote glioblastoma pathogenesis, but do not enhance targeted PI3K inhibition. PLoS One 13:e0200014
Graham-Gurysh, Elizabeth; Moore, Kathryn M; Satterlee, Andrew B et al. (2018) Sustained Delivery of Doxorubicin via Acetalated Dextran Scaffold Prevents Glioblastoma Recurrence after Surgical Resection. Mol Pharm 15:1309-1318
Hanson, Erik D; Danson, Eli; Evans, William S et al. (2018) Exercise Increases MAIT Cell Cytokine Expression but not Activation or Homing Markers. Med Sci Sports Exerc :
Swords, Ronan T; Coutre, Steven; Maris, Michael B et al. (2018) Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, combined with azacitidine in patients with AML. Blood 131:1415-1424

Showing the most recent 10 out of 1525 publications